CINTA - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

null CINTA

Center for Innovative NeuroTech Advancement

CINTA


Rapidly transforming emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system.

Learn more >

News and Events

C-THAN Receives up to $8 Million in Funding over Five Years

The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN), housed within Northwestern Engineering’s Center for Innovation Global Health Technologies (CIGHT), has received up to $8 million in renewal funding over five years from the National Institutes of Health (NIH). Read MoreAboutC-THAN Receives up to $8 Million in Funding over Five Years »

St. John’s Research Institute part of global collaborative effort to develop point-of-care diagnostic technologies

The newly established Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT) Center led by Dr. David Erickson at Cornell Engineering and Dr. Saurabh Mehta, the Janet and Gordon Lankton Professor in the Division of Nutritional Sciences, Cornell University, USA will initially be up to a 5-year initiative. Read MoreAboutSt. John’s Research Institute part of global collaborative effort to develop point-of-care diagnostic technologies »

UMass Chan and UMass Lowell’s point-of-care technology initiative awarded $8.9 million renewal

UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies. Read MoreAboutUMass Chan and UMass Lowell’s point-of-care technology initiative awarded $8.9 million renewal »

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.